PAREXEL Intl - EPCU-Baltimore

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes2 trials
• Sickle cell disease1 trial
• Thalassaemia1 trial

Phase

• Phase 14 trials

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Novo Nordisk A/S4 trials

Running trials

• Recruiting

  A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication

  NCT07868354· Phase 1· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication

  NCT07855133· Phase 1· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

  NCT07566390· Phase 1· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes2 recruiting

Closed trials

• Completed

  A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

  NCT07023029· Phase 1· Novo Nordisk A/S· Source